EISAI RECEIVES APPROVAL FOR INDICATION EXPANSION OF ANTI-EPILEPTIC AGENT FYCOMPA? FOR USE IN PEDIATRIC PATIENTS

-
1 A. Fogarasi et al. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures Epilepsia.?2020 Jan;61(1):125-137.
-
2 J. Ben Renfroe et al. Adjunctive Perampanel Oral Suspension in Pediatric Patients From =2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy?J Child Neurol.?2019 Apr;34(5):284-294
-
3 ?The Epilepsies and Seizures: Hope Through Research. What are the epilepsies?? National Institute of Neurological Disorders and Stroke, accessed May 24, 2016,